LA
AZN icon

Lee Ainslie’s AstraZeneca AZN Stock Holding History

Lee Ainslie’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,185
Closed -$1.34M – 343
2021
Q3 		$1.34M Sell
11,185
-885
-7% -$103K 0.01% 229
2021
Q2 		$1.45M Sell
12,070
-15,095
-56% -$1.66M 0.01% 205
2021
Q1 		$2.7M Buy
27,165
+20,655
+317% +$2.08M 0.02% 125
2020
Q4 		$651K Buy
+6,510
New +$690K 0.01% 314

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Lee Ainslie's AZN Position: Q4 2021 in Review

Lee Ainslie sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 11,185 shares — an estimated $1.34M sold.

Lee Ainslie first reported a position in AZN in Q4 2020 and held it in 4 quarters. The position peaked at $2.7M in Q1 2021. 950 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

  • Lee Ainslie reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
  • Lee Ainslie sold 11,185 AstraZeneca shares in Q4 2021, an estimated $1.34M.
  • Lee Ainslie first reported a position in AstraZeneca in Q4 2020 and held it in 4 quarters.
  • Lee Ainslie's AstraZeneca position peaked at $2.7M in Q1 2021.
  • 950 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.